This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1943 Jun 18;97(2529):541-4.

doi: 10.1126/science.97.2529.541.

ENDOCRINE CONTROL OF PROSTATIC CANCER

PMID: 17773799
DOI: 10.1126/science.97.2529.541

ENDOCRINE CONTROL OF PROSTATIC CANCER

C Huggins. Science. 1943.

. 1943 Jun 18;97(2529):541-4.

doi: 10.1126/science.97.2529.541.

Author

PMID: 17773799
DOI: 10.1126/science.97.2529.541

No abstract available

PubMed Disclaimer

Similar articles

Endocrine control of prostatic cancer; hormone therapy and surgery on endocrine glands are combining to give increasing control over prostatic cancer.
FERGUSSON JD. FERGUSSON JD. Med World. 1958 Jun;88(6):509-14. Med World. 1958. PMID: 13551510 No abstract available.
Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
Bonkhoff H, Remberger K. Bonkhoff H, et al. Prostate. 1996 Feb;28(2):98-106. doi: 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J. Prostate. 1996. PMID: 8604398 Review.
[Prostatic specific antigen in the serum in prostatic cancer].
Fuse H, Akakura K, Akimoto S, Shimazaki J. Fuse H, et al. Hinyokika Kiyo. 1987 Jul;33(7):1049-53. Hinyokika Kiyo. 1987. PMID: 2446484 Japanese.
[Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen].
Usami M, Kotake T, Matsuda M, Okajima E, Osafune M, Akaza H, Niijima T, Aso Y, Araki T, Itatani H, et al. Usami M, et al. Hinyokika Kiyo. 1988 Oct;34(10):1853-63. Hinyokika Kiyo. 1988. PMID: 2977527 Clinical Trial. Japanese.
[Treatment of advanced prostatic cancer].
Hedlund PO. Hedlund PO. Lakartidningen. 2000 Aug 9;97(32-33):3466-9. Lakartidningen. 2000. PMID: 11037588 Review. Swedish.

See all similar articles

Cited by

Comparison of maximal and more maximal intermittent androgen blockade during 5-year treatment of advanced prostate cancer T3NxMx-1.
Dutkiewicz SA. Dutkiewicz SA. Int Urol Nephrol. 2012 Apr;44(2):487-92. doi: 10.1007/s11255-011-0051-6. Epub 2011 Sep 20. Int Urol Nephrol. 2012. PMID: 21932036 Clinical Trial.
Prostate cancer xenografts and hormone induced prostate carcinogenesis.
McLean DT, Strand DW, Ricke WA. McLean DT, et al. Differentiation. 2017 Sep-Oct;97:23-32. doi: 10.1016/j.diff.2017.08.005. Epub 2017 Sep 8. Differentiation. 2017. PMID: 28923776 Free PMC article. Review.
Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
Maitland NJ. Maitland NJ. Cancers (Basel). 2021 Jan 17;13(2):327. doi: 10.3390/cancers13020327. Cancers (Basel). 2021. PMID: 33477370 Free PMC article. Review.
Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects.
Omoto Y, Iwase H. Omoto Y, et al. Cancer Sci. 2015 Apr;106(4):337-43. doi: 10.1111/cas.12613. Epub 2015 Mar 9. Cancer Sci. 2015. PMID: 25611678 Free PMC article. Review.
Therapeutic Targeting of Myc.
Prochownik EV, Vogt PK. Prochownik EV, et al. Genes Cancer. 2010 Jun;1(6):650-659. doi: 10.1177/1947601910377494. Genes Cancer. 2010. PMID: 21132100 Free PMC article.

See all "Cited by" articles

LinkOut - more resources

Full Text Sources
- Atypon